Dutch-based Purac will invest $20 million to place its 60,000 square foot biomaterials and resorbable polymers manufacturing facility in Tucker, Georgia, with plans to create more than 30 new jobs.
Purac Biomaterials, a part of Dutch-based Purac, develops, manufactures and markets resorbable polymers and monomers worldwide under the PURASORB brand name. “We are very pleased with the support we received from the state of Georgia and DeKalb County in finding a location for Purac Biomaterials,” said Menno Lammers, managing director of Purac Biomaterials. Together, with our location in the Netherlands, this facility will enable us to further strengthen our leading role in biomedical polymers. We look forward to becoming part of the local community.”
“With Georgia’s rich resources and assets within the bioscience industry, Purac Biomaterials will find a good home in our state,” said Nathan Deal. “Being able to sit down with a company’s leaders to ask for their business is a tremendous advantage for economic development. This commitment will further help me in making Georgia the No. 1 place in the nation to do business.”
The Georgia Department of Economic Development said it led the recruitment of Purac Biomaterials with support from the DeKalb County Office of Economic Development and the Metro Atlanta Chamber of Commerce.
“We are excited about the location of Purac Biomaterials in DeKalb County,” DeKalb County CEO Burrell Ellis said. “With the Centers for Disease Control, Emory Healthcare, Children’s Healthcare of Atlanta, and DeKalb Medical Center located nearby, we think that there will be a natural synergy for Purac Biomaterials’ new location in Tucker. This is the result of DeKalb County's collaboration with the Georgia Department of Economic Development, a true partner in stimulating investment and job creation.”
“Purac’s selection of Metro Atlanta for its North American R&D and specialty polymer production is recognition of our region’s robust growth in pharmaceutical and other health-related markets,” said David Hartnett, vice president bioscience and health IT development for the Metro Atlanta Chamber. “This new facility will take advantage of our uniquely skilled labor mix in metropolitan Atlanta, and it adds to an already impressive supply chain existing here for medical devices and drug delivery products.”
Economic development officials said, as an incentive to attract the firm, the state offered robust public-private partnerships in bioscience, including the Georgia Research Alliance. As part of the Alliance the state’s six research universities collaborate with businesses to create, improve and grow science- and technology-based companies. Additionally, Georgia boasts a strong talent pool and one of the largest state university systems in the country, graduating 44,000 students each year.